|
The purpose of this
course is to provide information and educate the reader about
Guillain-Barre¢ Syndrome (GBS). To inform the reader on the etiology,
tests, treatments and nursing management of GBS.
At the completion of
this course the leaner will be able to do the five following things:
|
1. |
define Guillain-Barre¢
syndrome, |
|
|
|
|
2. |
list possible triggers to
this disorder, |
|
|
|
|
3. |
identify symptoms of
Guillain-Barre¢ syndrome,
|
|
|
|
|
4. |
identify the three tests
that help diagnosis GBS, and
|
|
|
|
|
5. |
describe the key roles in
nursing management. |
Guillain-Barre syndrome (GBS) is a
demyelinating disease that is most
often seen several weeks after a
variety of nonspecific viral or
other infectious diseases. It is a
rare inflammatory disorder of the
peripheral nervous system. The
inflammation damages portions of the
nerve cell resulting in muscle
weakness, paralysis or sensory
disturbances. The damage involves
loss of the nerve’s myelin sheath
(demyelination), which slows the
conduction of impulses through the
nerve. The damage may also involve
destruction of the axon part of the
nerve cell (denervation), which
blocks conduction through the nerve.
The body’s immune system produces
antibodies that attack the
peripheral nerves. It is often
referred to as Acute Idiopathic
Polyneuropathy, or Acute
Inflammatory Demyelinating
Polyradiculoneuropathy (AIDP)
(McLeod, ND).
GBS is an inflammation of the
peripheral nerve, inflammation ends
in the suffix itis and so it is
sometimes called neuritis. When many
nerves are involved it is referred
to as polyneuritis. In GBS it is
more specific to the nerve roots
(points of attachment of the
peripheral nerves to the spinal
cord) is termed radiculo. The
meaning of diseases with the suffix
pathy, which leads to the name
polyradiculoneuropathy, is an
inflammation of many peripheral
nerves and nerve roots. Idiopathic
can be applied to the name because
idiopathic signifies that the cause
of the disease is unknown, as in the
case with GBS.
Guillain Barre¢ Syndrome is
considered an autoimmune disease.
Normally your body’s immune system
recognizes the body as “itself” and
ignores it, attacking only
introduced particles and invading
organisms. This mechanism can be
disrupted, as seen with GBS. The
body’s immune system mistakenly
turns against itself, attacking its
own tissues; this effect/reaction is
known as autoimmune (NINNDS, 2003).
Peripheral nerves transmit signals
from the brain and spinal cord to
and from the muscles, organs and
skin. Depending on their function,
the nerves can be classified as
motor, sensory and autonomous
(involuntary) peripheral nerves.
The immune system is responsible for
the production of special proteins,
and antibodies or immunoglobulins
(IG), as part of the body’s normal
defense mechanism. These antibodies
are produced in reaction to the
presence of antigens, or introduced
particles in the body, such as
various bacteria and vira.
Antibodies match specific antigens,
and when the two come in contact,
they bind together and a number of
destructive reactions occur.
GBS is rare and afflicting about one
to two person in 100,000. It is
unknown why GBS infects certain
people and not others. GBS is
neither hereditary nor contagious.
It can affect anybody at any age,
any race, and can be acquired during
any season or geographic area. A
definitive cause is unknown, but it
is believed to be triggered by a
viral or bacterial infection that
somehow causes an autoimmune. A
humoral etiology is supported
because antibody activity is
directed toward peripheral nervous
system (PNS) tissue, and
immunoglobulin deposits have been
found along myelin sheaths of the
PNS. GBS is preceded in
approximately 60% of the cases by a
respiratory or GI virus.
The body’s immune system begins to
attack the body itself. The
macrophages and T-cells attack the
healthy myelin in peripheral and
cranial nerves, and the central
nervous is unaffected. Usually the
cells of the immune system attack
only foreign material and invading
organisms. In Guillain-Barre
syndrome, the immune system starts
to destroy the myelin sheath that
surrounds the axons of many
peripheral nerves, or even the axons
themselves. Axons are long, thin
extensions of the nerve cells that
transmit the signals between the
nerve cells. Some axons are
surrounded by a myelin sheath. Think
of it as an electrical cable
surrounded by plastic broken up into
bead like segments with spaces in
between. The spaces between the
myelin sheaths are called Ranvier
Nodes. The axons are uncovered
between these nodes of Ranvier and
are vulnerable to attack. The myelin
sheath insulates and protects the
nerve cells. It also increases both
the speed and the distance over
which nerve signals can be
transmitted.
Listed below are some possible
common and uncommon triggers of GBS.
|
Common |
|
|
|
|
Upper respiratory tract
infections |
|
|
|
|
Gastrointestinal -diarrhea
illness due to campylobacter
jejuni |
|
|
|
|
Cytomegalovirus infection |
|
|
|
|
Epstein-barr virus infection |
|
|
|
|
Hepatitis A, B, C infection |
|
|
|
|
Human immunodeficiency virus
infection |
|
|
|
|
Borrelia burgdorferi
infection |
|
|
|
|
Lymphoma |
|
|
|
|
Trauma |
|
|
|
|
Uncommon |
|
|
|
|
Mycoplasma infection |
|
|
|
|
Leptospira
icterohaemorrhagiae
infection |
|
|
|
|
Surgery |
|
|
|
|
Salmonellosis |
|
|
|
|
Rabies vaccine |
|
|
|
|
Tetanus Toxoid |
|
|
|
|
Bacilli Calmette-guerin
immunization |
|
|
|
|
Sarcoidosis |
|
|
|
|
Systemic Lupus Erythematous |
|
|
|
|
(Shoemaker, Ayers, Grenvik,
& Holbrook, 2000) |
Clinical Features of Guillain-Barre¢
Syndrome (McLeod, ND)
|
Paresthesias in the hands
and feet |
|
|
|
|
Back pain in approximately
30% of cases |
|
|
|
|
Depressed or absent tendon
reflexes |
|
|
|
|
Progressive symmetrical
weakness of the limbs |
|
|
|
|
Cranial nerves are affected
(especially the facial
nerves) in approximately 50%
of cases |
|
|
|
|
Progression to peak
disability in four weeks |
Symptoms of Guillain-Barre¢ can
range from mild to extreme. In mild
cases, the patient may only have
slight weakness in walking,
requiring a cane or crutches. In the
more extreme cases the weakness may
progress to the point where the
patient is almost totally paralyzed,
possibly requiring mechanical
ventilation. Ascending motor
weakness can develop over 2-4 weeks,
and can be acute or sub acute. This
is followed by a gradual recovery
period that could last weeks to many
months. Most people will have
complete recovery from even the most
severe cases of GBS, but there are
some patients that continue to have
some residual weakness.
The main complaint is of weakness
that varies widely in severity in
different patients and often has a
proximal emphasis and symmetric
distribution. It usually begins in
the legs, spreading to a variable
extent but frequently involves the
arms and often one or both sides of
the face. Back pain is present in
approximately 1/3 of GBS cases. The
muscles of respiration or
deglutition may also be affected.
Cranial nerve deficits can be
presented either alone or associated
with limb weakness. Deep tendon
reflexes are usually absent, while
pupils and eyelids are often spared.
The paresis, weakness, and pain
follow an ascending pathway,
ultimately involving the upper
extremities and the cranial nerves.
Signs and symptoms are symmetrical
and may or may not include a sensory
component. Paraesthesias are
initially described as tingling,
prickling, pins-and-needles
sensations followed later by
needlelike and burning sensations.
Sensory nerves tell us about our
surroundings; whether we are hurt;
or if something is smooth or rough,
hot or cold. Sensory symptoms are
less common, but distal paresthesias
and dysethesias are common.
Neuropathy or radicular pain is
present in many patients. The
sensory disruptions are thought to
be related to ectopic activity from
damaged inhibitory neurons.
Gradually muscle pain is experienced
in the large muscles, such as the
thighs, back and shoulders.
Stiffness and cramping pain or deep
aching muscle pain is common. As the
sensory nerves are attacked the
patient experiences loss or
reduction of the sense of touch, or
abnormal sensations such as burning,
tingling, pins and needles, ants
under the skin sensation or
vibrations, and numbness.
Motor nerves control movement and
damage to them results in partially
or completely blocked signals. The
body is affected when the damaged
nerve loses its ability to function
normally, resulting in reduced
movement or coordination. The
patient experiences this as a
communication breakdown between what
he wants to do and his ability to do
it.
Autonomic nerves control the inner
organs whose function is normally
carried out automatically, such as
secretion of hormones, heartbeat,
urination, breathing, and vision.
These functions may be disrupted
resulting in arrhythmia, unstable
blood pressure, blurred or double
vision, dizziness, fainting spells,
inability to regulate the body
temperature, difficulty breathing,
reduced ability to control the
functions of the stomach, and
digestive system. Loss of weight,
vomiting after meals, reduced
function of various glands,
incontinence, and impotency may be
seen. Autonomic disturbances are
also common, may be severe, and are
sometimes life threatening such as
tachycardia, and pulmonary
dysfunction. Other symptoms may
occur such as sweating, facial
flushing and impaired sphincter
control. Cardiac dysrhythmias,
abnormal hemodynamic response to
drugs, and pupil dysfunction are
common signs and symptoms of
autonomic dysfunction.
Acute ventilatory failure is a
common and devastating complication
explained by the loss of motor
innervation to skeletal muscles of
the chest and diaphragm. With
decreased inspiratory and expiratory
capacities, coughing becomes
ineffective, and the airway is
compromised, leading to hypoxia,
atelectasis, pneumonia, and
aspiration. Aspiration occurs as a
direct result of weakened laryngeal
and glottis musculature. Airway
obstruction occurs as a result of
tongue and retropharyngeal weakness.
Alveolar hypoventilation, along with
impaired carbon dioxide levels also
may occur. The patient is put at
great risk, since the clinical signs
of impaired respiratory function,
such as hypercarbia, occur well
before impaired respiratory function
occurs. This is why it is important
that serial measurements of
respiratory parameters, including
respiratory rate and pattern,
(observing for paradoxical breathing
and frequent changes in muscle use
or use of accessory muscles) are
completed along with frequent tidal
volume, and vital capacity checks
(McLeod, ND).
Possible life threatening symptoms
of GBS that require close monitoring
(McLeod, ND):
|
1. |
Difficulty breathing
(dyspnea) or taking deep
breaths, breathlessness
(SOB) |
|
|
|
|
2. |
Drooling, difficulty
swallowing (dysphagia) |
|
|
|
|
3. |
Fainting spells (syncope) |
Etiologies of other rapidly
progressive weakness of muscles
(McLeod, ND):
|
Transverse myelitis |
|
|
|
|
Myasthenia Gravis |
|
|
|
|
Poliomyelitis |
|
|
|
|
Acquired hypokalemia |
|
|
|
|
Periodic paralysis |
|
|
|
|
Botulism |
Other etiologies of Acute
Polyneuritis (McLeod, ND):
|
HIV |
|
|
|
|
Acute Intermittent Porphyria |
|
|
|
|
Vitamin B deficiencies |
|
|
|
|
Heavy metals and other
toxins |
|
|
|
|
Lymphoma, Carcinoma |
|
|
|
|
Lyme disease |
|
|
|
|
Vasculitis |
|
|
|
|
Diphtheria |
|
|
|
|
Diabetes |
Lumbar puncture (spinal tap)
The patient is given a local
anesthetic and then a needle is
inserted between the third and
fourth lumbar vertebrae into the
fluid filled area that surrounds the
nerve roots, and a sample of
Cerebrospinal fluid (CSF) is
obtained. CSF surrounds the brain
and spinal cord, and acts as a
buffer. It is normally clear and
colorless. Changes in its color,
quantity or composition may be an
indication of neurological damage or
disease. An elevated level of
protein in the fluid is
characteristic of GBS.
Electromyogram (EMG)
EMG examines the activity in the
muscles for any signs of slowing
down or blocking of response to
nerve signals. It is used to
differentiate between muscle
disorders and muscle weakness caused
by neurological disorders. When a
nerve is stimulated with a brief
electrical impulse that feels like a
tiny volt, it creates activity in
the adjoining muscle. This activity
can be measured. A thin electrode is
pushed through the patient’s skin,
into the muscle to be examined. It
is connected to a screen that shows
the electrical activity being
measured by the electrode. When the
patient contracts the muscle, by
bending it, the muscle fibers
affected by the movement produce
electrical activity being measured
by the electrode. A muscle that is
not in use will not produce
electrical impulses, and no signal
will be seen on the screen
(Anonymous, 2001).
Nerve conduction velocity (NCV)
NCV is a test that investigates how
well the nerves function. Nerves
with damaged myelin transmit signals
slower than undamaged nerve cells,
while nerves with destroyed axons
cannot transmit signals at all. This
test reveals whether the ability of
the tested nerves to transmit
signals is reduced. This test can in
some cases indicate what may have
caused the disease. During the test,
flat electrodes are placed on the
patient’s skin at intervals, above
the nerve to be examined for damage.
One of the electrodes stimulates the
nerve by transmitting a very weak
electrical impulse through it. The
other electrodes pick up and measure
the strength of the impulse that
reaches them. The conduction
velocity of the nerve is calculated
from the distance between the
electrodes and the time it takes for
the impulse to move between them.
The speed of transmission is related
to the diameter of the nerve and its
myelination. The result is therefore
compared with the speed of
transmission of an undamaged nerve.
The impulse may feel a little like
an electric shock, and depending on
how strong it is, it will be felt by
the patient in varying degrees and
may be uncomfortable for some
patients. This test is performed
along with the EMG; it records the
speed at which the signals travel
along the nerves (Anonymous, 2001).
Electrocardiogram (EKG)
An EKG records the electrical
activity of the heart, and indicates
any irregularities in the heart’s
rhythm. Electrodes are applied to
the chest. Activity of the heart
produces small electrical impulses
that are picked up and measured by
the electrodes, after which the
heart rhythm can be seen on the
screen (Anonymous, 2001).
Nerve
Biopsy
A nerve biopsy may be necessary in
rare cases. This requires the
removal of a tiny piece of nerve,
under local anesthesia. The section
is examined under a microscope for
signs of damage. Some patients
complain of sensory disturbances in
the area a long time after the
biopsy is completed (Anonymous,
2001).
There is no cure for GBS, but there
are some therapies that can help
lessen the severity of this illness
and speed up recovery. Treatment
begins as soon as the diagnosis is
verified. Its aim is to reduce
symptoms, offer immunotherapy to
attempt to shorten the duration of
the disease, and maintain the body’s
muscles.
The patient should be sent to a
hospital immediately if symptoms
persist or increase in severity.
These symptoms need to be carefully
evaluated. If these signs and
symptoms start to escalate the
patient should be transferred or
admitted to an ICU unit for close
observation where respiratory
therapy and continuous cardiac
monitoring are available.
|
1. |
Treat respiratory failure |
|
|
|
|
2. |
Cardiac monitoring |
|
|
|
|
3. |
Specific treatment therapies |
|
|
|
|
4. |
Intragastric or intravenous
feedings |
|
|
|
|
5. |
General nursing care |
|
|
|
|
6. |
Prevent deep vein thrombosis |
|
|
|
|
7. |
Psychological support and
communication |
Treat respiratory failure
Increasing muscular paralysis can
temporarily affect the chest
muscles, causing shortness of
breath. The patient may be required
to be put on a ventilator. The
ventilator helps to stabilize and
assist the patient’s respirations.
Most patients may only need to be on
a ventilator for 1-2 weeks, while
others will need it for longer
periods of time. The patients that
need mechanical ventilation for
increased periods of time may need a
tracheostomy. This is a surgical
procedure where a small slit is made
into the throat and a tracheostomy
tube is inserted through the hole
into the windpipe/trachea.
Frequent suctioning may be required.
This is done through the
tracheostomy tube or the
endotracheal tube. Suctioning helps
to keep the lungs free of secretions
that may hinder breathing.
Sedation and pain medications should
be used as needed. Many people
require light sedation to help
prevent them from fighting against
the ventilator or pulling at the
ventilator tubing. Pain medication
is also crucial at this point.
Patients still have pain and need to
be properly medicated. This may also
help reduce anxiety.
Communication is vital while
patients are on mechanical
ventilator. Effective communication
must be established between the
patient, family, medical and nursing
staff. The patient should be
involved in the decision making
process regarding their treatment
and care. Communication can be
sought out by using alphabet boards,
pictures, dry erase boards, or
pencil and paper. Some patients are
only able to shake their head or
blink their eyes for yes and no
answers.
Cardiac Monitoring
The patent should be monitored for
arrhythmias, and changes in blood
pressure. These changes can reflect
peripheral autonomic nervous system
involvement.
Specific Treatment Therapies
Plasmapheresis, also known as plasma
exchange, can be thought of as blood
cleaning. This treatment involves
either removal of the patient’s
antibodies or the addition of other
antibodies to the patent or a
combination of both. Plasmapheresis
is done by removing whole blood from
the body and processing it so that
the red and white blood cells are
separated from the plasma. The blood
cells are then returned to the
patient without the plasma where the
body quickly manufactures more
plasma to replace what was removed
during Plasmapheresis. This process
is thought to be effective because
the plasma that contained toxic
elements that could destroy myelin
is processed out of the whole blood.
Immunoglobulin infusion is done via
intravenous infusion. Immunoglobulin
contains healthy antibodies from
blood donors. High doses of
intravenous infusions of
immunoglobulin are thought to block
the antibodies that could damage
myelin that contribute to GBS; this
process can help lessen the immune
attack on the nervous system.
Together these specific treatment
therapies help to reduce the
severity of the disease. These
treatments help reduce destruction
which in turn helps to reduce
damage. They work together to
decrease the time it takes to
recover. The patient and family need
to be educated about these
processes, and that recovery is
spontaneous, which makes it
impossible to know how many
treatments may be needed.
Intragastric or Intravenous Feedings
Patients that can swallow may need
assistance with feeding. Swallowing
studies maybe necessary to determine
the consistency of fluids or foods
that are needed to help decrease the
risk of aspiration. The head of the
bed should be elevated 30-45° to
help prevent aspiration. Patients
that have difficulty swallowing are
given fluids, nourishment and
medicine through an intravenous line
or nasal gastric tube.
General Nursing Care
Respiratory: Observe for changes in
respiratory pattern, shortness of
breath, dyspnea, and suction
increased secretions.
Cardiac: Look for changes in cardiac
rhythms, increased ectopy, and blood
pressure. Assess for chest pain or
discomfort.
Gastric feeding: The head of the bed
should be elevated 30-45° to help
decrease the risk of aspiration.
Mouth: The nurse should look for
drooping and or drooling from the
mouth, and complaints of dysphagia.
Bowels: Bowel movements should be
documented. Nausea and/or vomiting
could be signs of constipation.
Medications should be ordered
routine or prn to help prevent
constipation.
Bladder: The bladder can temporarily
lose its ability to squeeze and
empty itself, which can lead to
urinary retention. If this happens a
foley catheter should be inserted.
Daily foley and perineal care should
be done routinely to help prevent
urinary tract infections.
Skin: The patient’s skin should be
inspected every shift for potential
breakdown. Patients should be turned
and repositioned q 2 hours to
decrease the risk of pressure ulcers
and promote circulation. Feet and
hands should be assessed for foot or
wrist drop.
Deep Vein Thrombosis
Bedridden patients are at high risk
for developing DVT. Prophylactic
anti-thrombolytics should be ordered
such as subcutaneous heparin 5,000
units B.I.D.
Physical Therapy
Arrangements for physical therapy
should be initiated as soon as
possible for the patient to have
optimal recovery. Caregivers may
need to be taught how to manually
move the patient’s arms and legs to
help keep the muscles flexible and
strong. Whirlpool therapy may help
to relieve pain. Once discharged the
patient should be sent home with an
active exercise routine to help
regain muscle strength. Patients
should be evaluated for splints,
walking aids and rehabilitation.
Psychological Support and
Communication
Patients and family members need to
be involved in all aspects of care.
They need to be informed that the
course of the disease is
unpredictable, but the majority of
patients recover. The patient should
be allowed to communicate his or her
feelings of frustration, pain,
anxiety, isolation, and low
self-esteem. Counseling and
medication to help deal with these
feelings may be necessary for a
while for both patient and family.
There are many support groups for
Guillain Barre Syndrome for patients
and their families. These support
groups can be found on the Internet,
in the phone book, or at your local
library.
Guillain-Barre Syndrome Foundation
International
P.O. box 262
Wynnewood, PA 19096
Anonymous (2001). All about
Guillain-Barre Syndrome, Retrieved
7/03 from
http://www.jsmarcussen.com/gbs/uk/diagnosis.htm,
http://www.jsmarcussen.com/gbs/uk/symptoms.htm,
http://www.jsmarcussen.com/gbs/uk/incidence.htm,
http://www.jsmarcussen.com/gbs/uk/damage.htm,
http://www.jsmarcussen.com/gbs/uk/treatment.htm,
http://www.jsmarcussen.com/gbs/uk/overview.htm
Anonymous. (ND). Guillain-Barre
Syndrome. Retrieved 7/03 from
http://www.physicaltherapy.ca/neuro/Gbsyndrome.html.
Bongard, F.S., Sue, D.Y., (1994).
Current Critical Care Diagnosis and
Treatment. Connecticut: Appleton and
Lange (pg. 533).
Health communities Neurology
Channel, (2003). Guillain-Barre
Syndrome. Retrieved 7/03 from
http://www.neurologychannel.com/guillain/
Kinney, M.R., Dunbar, S.B.,
Brooks-Brunn, J., Molter, N.,
Vitello-Cicciu, J. (1998). AACN
Clinical Reference for Critical Care
Nursing (4th ed.). Missouri: Mosby,
Inc (pg. 720-722).
Mayo Foundation for Medical
Education and Research (MFMER)
(1998-2003). Guillain-Barre
Syndrome. Retrieved 7/03 from
http://www.mayoclinic.com/invoke.cfm.
McLeod, J. (ND) Reprinted from
Modern Medicine of Australia. GBS- a
GP’s guide to diagnosis and
management. Retrieved 7/03 from
http://members.ozemail.com.au/~guillain/gp.htm.
National Institute of Neurological
Disorders and Stroke NINNDS, (2003).
Gillian Barre Syndrome Fact Sheet.
Retrieved 7/03 from
http://www.ninds.nih.gov.health_and_medical/pubs/guillain_barre.htm
Shoemaker, Ayers, Grenvik, &
Holbrook. (2000) Textbook of
Critical Care (4th ed.)
Pennsylvania: Saunders (pg.
1888-1889).
Tierney, Jr. L.M., McPhee, S.J.,
Papadakis, M.A. (2000)
Current-Medical Diagnosis and
Treatment (39th ed.). New York:
McGraw-Hill companies (pg.
1006-1007).
Wynngaarden, JB, Smith, LH, Bennet,
JC (1996). Cecil Textbook of
Medicine, (20th ed.). WB Saunders
Company, Retrieved 7/03 from
http://www.medstudents.com.br/nero/neurol.htm. |